Kestra Medical Techs (KMTS) closed at $29.69 on October 30, 2026, down 3.0% from the previous close, on volume of 314,665 shares (30-day average 398,873).
Data as of October 30, 2026.
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
Globe Newswire (Fri, 30-Oct 6:00 AM ET)
Globe Newswire (Thu, 1-Oct 6:00 AM ET)
CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors
Business Wire (Thu, 24-Sep 3:49 AM ET)
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Globe Newswire (Mon, 14-Sep 4:01 PM ET)
Kestra Names Daniel Finney Vice President of Research & Development
Globe Newswire (Thu, 10-Sep 6:00 AM ET)
Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
Globe Newswire (Mon, 31-Aug 4:01 PM ET)
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
Globe Newswire (Wed, 26-Aug 6:00 AM ET)
Market Chameleon (Wed, 3-Dec 5:34 AM ET)
KMTS to Reveal Q2 Fiscal 2026 Results: Key Dates and What Investors Should Watch
Market Chameleon (Wed, 3-Dec 3:59 AM ET)
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of October 30, 2026, KMTS stock price declined to $29.69 with 314,665 million shares trading.
KMTS has a beta of 1.22, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.06 to the broad based SPY ETF.
KMTS has a market cap of $1.77 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $31 million in Revenue and -$.75 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.13.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, VXF, IWO, FYC.
KMTS has underperformed the market in the last year with a return of +6.2%, while SPY returned +12.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in KMTS shares. However, KMTS has outperformed the market in the last 3 month and 2 week periods, returning +28.3% and +9.0%, while SPY returned +2.1% and -1.0%, respectively. This indicates KMTS has been having a stronger performance recently.
KMTS support price is $29.22 and resistance is $32.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.
